Ageing-related markers and risks of cancer and cardiovascular disease: a prospective study in the EPIC-Heidelberg cohort
Open Access
- 22 December 2021
- journal article
- research article
- Published by Springer Nature in European Journal of Epidemiology
- Vol. 37 (1) , 49-65
Abstract
Biological age is an important risk factor for chronic diseases. We examined the associations between five markers of unhealthy ageing; Growth Differentiation Factor-15 (GDF-15), N-terminal pro-brain natriuretic peptide (NT-proBNP), glycated hemoglobin A1c (HbA1C), C-Reactive Protein (CRP) and cystatin-C; with risks of cancer and cardiovascular disease (CVD). We used a case-cohort design embedded in the EPIC-Heidelberg cohort, including a subcohort of 3792 participants along with 4867 incident cases of cancer and CVD. Hazard ratios (HRs) were computed and the strongest associations were used to build weighted multi-marker combinations, and their associations with cancer and CVD risks were tested. After adjusting for common confounders, we observed direct associations of GDF-15 with lung cancer risk, NT-proBNP with breast, prostate and colorectal cancers, HbA1C with lung, colorectal, and breast cancer risks, and CRP with lung and colorectal cancer risks. An inverse association was observed for GDF-15 and prostate cancer risk. We also found direct associations of all 5 markers with myocardial infarction (MI) risk, and of GDF-15, NT-proBNP, CRP and cystatin-C with stroke risk. A combination of the independently-associated markers showed a moderately strong association with the risks of cancer and CVD (HRQ4-Q1ranged from 1.78[1.36, 2.34] for breast cancer, when combining NT-proBNP and HbA1C, to 2.87[2.15, 3.83] for MI when combining NT-proBNP, HbA1C, CRP and cystatin-C). This analysis suggests that combinations of biomarkers related to unhealthy ageing show strong associations with cancer risk, and corroborates published evidence on CVD risk. If confirmed in other studies, using these biomarkers could be useful for the identification of individuals at higher risk of age-related diseases.Keywords
Funding Information
- Helmholtz-Gemeinschaft (AMPro ZT-0026)
- Fondation Bettencourt Schueller
- Deutsches Krebsforschungszentrum (DKFZ)
This publication has 67 references indexed in Scilit:
- Testing the proportional hazards assumption in case-cohort analysisBMC Medical Research Methodology, 2013
- The Hallmarks of AgingCell, 2013
- C-Reactive Protein, Interleukin 6 and Lung Cancer Risk: A Meta-AnalysisPLOS ONE, 2012
- Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older AdultsCirculation, 2011
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010
- C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysisThe Lancet, 2010
- C‐reactive protein and colorectal cancer risk: A systematic review of prospective studiesInternational Journal of Cancer, 2008
- Cystatin C and Aging SuccessArchives of internal medicine (1960), 2008
- Case-cohort design in practice – experiences from the MORGAM ProjectEpidemiologic Perspectives & Innovations, 2007
- European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collectionPublic Health Nutrition, 2002